2 months ago
VKTX
AnalystsSteven SeedhouseSteven Seedhouse's Stock Forecasts
AnalystsSteven Seedhouse
Sectors:
Industries:
Analyst Ranking
Top 11%
#492 out of 4560 analysts
Average Return
+6.83%
Win Rate
40%67 out of 168
Risk vs Reward
Poor
Good
Steven Seedhouse's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-11 - 2023-05-11 | Strong Buy |
89bio IncETNB | +450.31% | $3.22 | $17.72 | 2022-06-29 - 2023-06-29 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-28 - 2024-03-28 | Buy |
Vbi Vaccines IncVBIV | +376.54% | $16.87 | $80.40 | 2019-11-13 - 2020-11-13 | Buy |
Editas Medicine IncEDIT | +331.74% | $20.98 | $90.58 | 2020-02-26 - 2021-01-08 | Buy |
Steven Seedhouse Analyst Color
Get additional color on Steven Seedhouse's coverage of popular stocks
4 months ago
ARDX
4 months ago
DYN
a year ago
IFRX
a year ago
VKTX
a year ago
ETNB
a year ago
DYN
2 years ago
ETNB
2 years ago
APLS
2 years ago
APLS
3 years ago
MIRM
Steven Seedhouse's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dianthus Therapeutics IncDNTH | 2 | Buy | $51.00 | +117.76% | Maintains | 6 days ago |
Viking Therapeutics IncVKTX | 12 | Buy | $115.00 | +77.11% | Maintains | 2 months ago |
Cymabay Therapeutics IncCBAY | 7 | Hold | $32.50 | +0.06% | Downgrades | 2 months ago |
Vera Therapeutics IncVERA | 2 | Strong Buy | $37.00 | -6.38% | Upgrades | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 14 | Strong Buy | $106.00 | +117.57% | Maintains | 3 months ago |
Ardelyx IncARDX | 2 | Strong Buy | $15.00 | +134.74% | Maintains | 4 months ago |
Dyne Therapeutics IncDYN | 4 | Strong Buy | $56.00 | +120.13% | Maintains | 4 months ago |
Mirum Pharmaceuticals IncMIRM | 15 | Strong Buy | $64.00 | +162.08% | Maintains | 4 months ago |
Leap Therapeutics IncLPTX | 8 | Buy | $17.50 | +446.88% | Maintains | 5 months ago |
Intellia Therapeutics IncNTLA | 7 | Buy | $57.00 | +164.75% | Maintains | 5 months ago |
Proqr Therapeutics NvPRQR | 4 | Buy | $4.00 | +98.02% | Maintains | 6 months ago |
Inflarx NvIFRX | 9 | Strong Buy | $19.00 | +1,297.06% | Maintains | 6 months ago |
Zura Bio LtdZURA | 2 | Strong Buy | $22.00 | +532.18% | Maintains | 8 months ago |
Wave Life Sciences LtdWVE | 1 | Buy | $7.00 | +37.80% | Initiates Coverage On | 10 months ago |
Editas Medicine IncEDIT | 3 | Buy | $17.00 | +211.36% | Upgrades | 10 months ago |
Rocket Pharmaceuticals IncRCKT | 4 | Buy | $35.00 | +47.87% | Maintains | a year ago |
Kymera Therapeutics IncKYMR | 2 | Buy | $38.00 | +6.41% | Upgrades | a year ago |
Intercept Pharmaceuticals IncICPT | 10 | Buy | $31.00 | +63.16% | Maintains | a year ago |
Vbi Vaccines IncVBIV | 7 | Buy | $6.00 | N/A | Maintains | a year ago |
89bio IncETNB | 7 | Strong Buy | $50.00 | N/A | Maintains | a year ago |
Avidity Biosciences IncRNA | 4 | Strong Buy | $71.00 | N/A | Maintains | a year ago |
Gossamer Bio IncGOSS | 5 | Buy | $5.00 | N/A | Maintains | a year ago |
Neximmune IncNEXI | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Jounce Therapeutics IncJNCE | 8 | Buy | $3.00 | N/A | Downgrades | a year ago |
Anaptysbio IncANAB | 2 | Buy | $38.00 | N/A | Maintains | a year ago |
Ngm Biopharmaceuticals IncNGM | 8 | Buy | $6.00 | N/A | Maintains | a year ago |
Landos Biopharma IncLABP | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Sell | N/A | N/A | Downgrades | 2 years ago |
Chemocentryx IncCCXI | 7 | Hold | N/A | N/A | Downgrades | 2 years ago |
Galmed Pharmaceuticals LtdGLMD | 4 | Buy | $75.00 | N/A | Maintains | 2 years ago |
Gyre Therapeutics IncGYRE | 1 | Buy | $18.00 | N/A | Maintains | 3 years ago |
Kadmon Holdings IncKDMN | 1 | Buy | $10.00 | N/A | Maintains | 3 years ago |
Alexion Pharmaceuticals IncALXN | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Biogen IncBIIB | 2 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Gilead Sciences IncGILD | 1 | Buy | $80.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.